Northrop Grumman Corporation (NOC) Stock Forecast
Data as of May 2, 2026Industrials · Current price $570.95 (-1.48%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 29, 2026 | Scott Deuschle | Deutsche Bank | $765.00 | +34.0% |
| Jan 28, 2026 | Andre Madrid | BTIG | $815.00 | +42.7% |
| Jan 27, 2026 | Robert Stallard | Vertical Research | $688.00 | +20.5% |
| Jan 12, 2026 | Douglas Harned | Bernstein | $727.00 | +27.3% |
| Dec 16, 2025 | Kristine Liwag | Morgan Stanley | $714.00 | +25.1% |
| Dec 15, 2025 | Peter Skibitski | Alembic Global | $662.00 | +15.9% |
| Oct 22, 2025 | Andre Madrid | BTIG | $680.00 | +19.1% |
| Oct 15, 2025 | Kristine Liwag | Morgan Stanley | $720.00 | +26.1% |
| Oct 8, 2025 | Scott Deuschle | Deutsche Bank | $700.00 | +22.6% |
| Jul 22, 2025 | Charles Minervino | Susquehanna | $540.00 | -5.4% |
| Apr 24, 2025 | Matthew Akers | Wells Fargo | $525.00 | -8.0% |
| Apr 23, 2025 | Michael Ciarmoli | Truist Financial | $550.00 | -3.7% |
| Jan 8, 2025 | Charles Minervino | Susquehanna | $557.00 | -2.4% |
| Oct 30, 2024 | Sheila Kahyaoglu | Jefferies | $550.00 | -3.7% |
| Oct 29, 2024 | David Strauss | Barclays | $550.00 | -3.7% |
| Oct 11, 2024 | Douglas Harned | Bernstein | $565.00 | -1.0% |
| Oct 10, 2024 | Jason Gursky | Citigroup | $587.00 | +2.8% |
| Sep 26, 2024 | Kristine Liwag | Morgan Stanley | $592.00 | +3.7% |
| Jul 26, 2024 | Peter Arment | Robert W. Baird | $470.57 | -17.6% |
| Jul 26, 2024 | Ken Herbert | RBC Capital | $500.00 | -12.4% |
Top Analysts Covering NOC
NOC vs Sector & Market
| Metric | NOC | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.18 | 2.41 | 2.41 |
| Analyst Count | 17 | 8 | 18 |
| Target Upside | +28.1% | +84.9% | +14.9% |
| P/E Ratio | 17.87 | 28.17 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $43.60B | $43.97B | $44.13B | 17 |
| 2027-03-31 | $10.43B | $10.54B | $10.65B | 6 |
| 2027-06-30 | $11.46B | $11.57B | $11.69B | 6 |
| 2027-09-30 | $11.63B | $11.75B | $11.87B | 6 |
| 2027-12-31 | $12.98B | $13.12B | $13.25B | 6 |
| 2028-03-31 | $10.87B | $10.98B | $11.10B | 6 |
| 2028-06-30 | $11.99B | $12.11B | $12.24B | 5 |
| 2028-09-30 | $12.16B | $12.28B | $12.41B | 5 |
| 2028-12-31 | $13.67B | $13.81B | $13.96B | 6 |
| 2029-12-31 | $51.06B | $51.87B | $52.90B | 11 |
| 2030-12-31 | $54.75B | $55.62B | $56.73B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $27.59 | $27.95 | $28.74 | 16 |
| 2027-03-31 | $6.54 | $6.63 | $6.72 | 4 |
| 2027-06-30 | $7.18 | $7.28 | $7.38 | 5 |
| 2027-09-30 | $7.41 | $7.51 | $7.61 | 8 |
| 2027-12-31 | $8.41 | $8.53 | $8.64 | 4 |
| 2028-03-31 | $7.03 | $7.13 | $7.22 | 5 |
| 2028-06-30 | $7.77 | $7.87 | $7.98 | 7 |
| 2028-09-30 | $7.99 | $8.10 | $8.21 | 10 |
| 2028-12-31 | $9.14 | $9.26 | $9.39 | 5 |
| 2029-12-31 | $33.68 | $34.37 | $35.26 | 11 |
| 2030-12-31 | $36.55 | $37.30 | $38.27 | 5 |
Frequently Asked Questions
What is the analyst consensus for NOC?
The consensus among 17 analysts covering Northrop Grumman Corporation (NOC) is Buy with an average price target of $736.31.
What is the highest price target for NOC?
The highest price target for NOC is $815.00, set by Andre Madrid at BTIG on 2026-01-28.
What is the lowest price target for NOC?
The lowest price target for NOC is $350.00, set by Noah Poponak at Goldman Sachs on 2021-09-23.
How many analysts cover NOC?
17 analysts have issued ratings for Northrop Grumman Corporation in the past 12 months.
Is NOC a buy or sell right now?
Based on 17 analyst ratings, NOC has a consensus rating of Buy (2.18/5) with a +28.1% upside to the consensus target of $736.31.
What are the earnings estimates for NOC?
Analysts estimate NOC will report EPS of $27.95 for the period ending 2026-12-31, with revenue estimated at $43.97B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.